CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele

被引:82
作者
Sim, SC
Edwards, RJ
Boobis, AR
Ingelman-Sundberg, M
机构
[1] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, SE-17177 Stockholm, Sweden
[2] Univ London Imperial Coll Sci & Technol, Div Med, Sect Expt Med & Toxicol, London, England
关键词
cytochrome P450; dehydroepiandrosterone; genetic polymorphism; peptide antibody;
D O I
10.1097/01.fpc.0000171516.84139.89
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Previously, cytochrome P450 3A7 (CYP3A7), which constitutes the major CYP enzyme in fetal livers, has been considered a fetus-specific enzyme. However, CYP3A7 mRNA has recently been shown to be expressed at significant levels in a subset of adult human livers, several of which carry the CYP3A7*lC allele that contains the proximal PXR/CAR element of CYP3A4. The objective of this study was to investigate CYP3A7 expression at the protein level by developing a CYP3A7-specific antibody to allow its quantification. Based on results from 59 adult human liver samples, we found significant CYP3A7 protein expression in approximately one in 10 adult livers amounting for 24-90 pmol/mg microsomal protein, thereby contributing 9-36% to total CYP3A levels in these livers. CYP3A7 protein was detected in five of seven livers carrying the CYP3A7*lC allele (two of which only had trace amounts), whereas an additional three livers expressing CYP3A7 were apparently homozygous for CYP3A7*1. The mean protein expression level of CYP3A7 was 42 pmol/mg within the group of livers expressing CYP3A7 and 4 pmol/mg in all liver samples. CYP3A7 expression was thus higher than that of the polymorphically expressed CYP3A5 in adult human livers, based on a comparison with a previous study using our CYP3A5 peptide-specific antibody. The relatively high level of CYP3A7 protein expression detected in a subset of adult livers may be relevant with respect to the metabolism of exogenous and endogenous substrates, such as retinoic acid and dehydroepiandrosterone.
引用
收藏
页码:625 / 631
页数:7
相关论文
共 28 条
[1]   Clinical uses and misuses of dehydroepiandrosterone [J].
Binello, E ;
Gordon, CM .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (06) :635-641
[2]   MONO-OXYGENASE ACTIVITY OF HUMAN-LIVER IN MICROSOMAL FRACTIONS OF NEEDLE-BIOPSY SPECIMENS [J].
BOOBIS, AR ;
BRODIE, MJ ;
KAHN, GC ;
FLETCHER, DR ;
SAUNDERS, JH ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (01) :11-19
[3]   Cytochrome P450 3A and their regulation [J].
Burk, O ;
Wojnowski, L .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) :105-124
[4]   Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine [J].
Burk, O ;
Tegude, H ;
Koch, I ;
Hustert, E ;
Wolbold, R ;
Glaeser, H ;
Klein, K ;
Fromm, MF ;
Nuessler, AK ;
Neuhaus, P ;
Zanger, UM ;
Eichelbaum, M ;
Wojnowski, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24280-24288
[5]  
Cooper Alan J, 2003, Australas J Dermatol, V44, P97, DOI 10.1046/j.1440-0960.2003.00653.x
[6]   Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans [J].
Edwards, RJ ;
Adams, DA ;
Watts, PS ;
Davies, DS ;
Boobis, AR .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (03) :377-387
[7]   The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture [J].
Greuet, J ;
Pichard, L ;
Bonfils, C ;
Domergue, J ;
Maurel, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (02) :689-694
[8]   Cytochrome P450 3A expression in the human fetal liver:: Evidence that CYP3A5 is expressed in only a limited number of fetal livers [J].
Hakkola, J ;
Raunio, H ;
Purkunen, R ;
Saarikoski, S ;
Vähäkangas, K ;
Pelkonen, O ;
Edwards, RJ ;
Boobis, AR ;
Pasanen, M .
BIOLOGY OF THE NEONATE, 2001, 80 (03) :193-201
[9]  
JIMENEZLARA AM, 2004, AUSTR J DERMATOL, V10, P508
[10]   Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA [J].
Koch, I ;
Weil, R ;
Wolbold, R ;
Brockmöller, J ;
Hustert, E ;
Burk, O ;
Neussler, A ;
Neuhaus, P ;
Eichelbaum, M ;
Zanger, U ;
Wojnowski, L .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (10) :1108-1114